farnesol and Cancer of Endometrium

farnesol has been researched along with Cancer of Endometrium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ben-Baruch, G; Faigenbaum, R; Haklai, R; Kloog, Y	1

Other Studies

1 other study(ies) available for farnesol and Cancer of Endometrium

Article	Year
Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib. Oncotarget, 2013, Volume: 4, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Endometrial Neoplasms; Estrogen Receptor alpha; Estrogen Receptor beta; Farnesol; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Phosphorylation; ras Proteins; RNA, Messenger; Salicylates; Transcription, Genetic	2013

Article

Year

Growth of poorly differentiated endometrial carcinoma is inhibited by combined action of medroxyprogesterone acetate and the Ras inhibitor Salirasib.

Oncotarget, 2013, Volume: 4, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Endometrial Neoplasms; Estrogen Receptor alpha; Estrogen Receptor beta; Farnesol; Female; Gene Expression Regulation, Neoplastic; Humans; Medroxyprogesterone Acetate; Phosphorylation; ras Proteins; RNA, Messenger; Salicylates; Transcription, Genetic

2013